BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer

dc.contributor.buuauthorErtürk, Elif
dc.contributor.buuauthorÇeçener, Gülşah
dc.contributor.buuauthorTezcan, Gülçin
dc.contributor.buuauthorEgeli, Ünal
dc.contributor.buuauthorTunca, Berrin
dc.contributor.buuauthorGökgöz, Şehsuvar
dc.contributor.buuauthorTolunay, Şahsine
dc.contributor.buuauthorTaşdelen, İsmet
dc.contributor.departmentUludağ Üniversitesi/Sağlık Meslek Yükseokulu/Tıbbi Laboratuvar Teknikleri Programı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyoloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Genel Cerrahi Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Tıbbi Patoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0001-7668-796Xtr_TR
dc.contributor.orcid0000-0002-3820-424Xtr_TR
dc.contributor.orcid0000-0002-5956-8755tr_TR
dc.contributor.orcid0000-0001-7904-883Xtr_TR
dc.contributor.orcid0000-0002-1619-6680tr_TR
dc.contributor.orcid0000-0003-1394-2630tr_TR
dc.contributor.orcid0000-0002-9038-0515tr_TR
dc.contributor.researcheridAAK-3371-2021tr_TR
dc.contributor.researcheridAAP-9988-2020tr_TR
dc.contributor.researcheridAAH-3843-2020tr_TR
dc.contributor.researcheridAAH-1420-2021tr_TR
dc.contributor.researcheridABI-6078-2020tr_TR
dc.contributor.researcheridEXK-4525-2022tr_TR
dc.contributor.researcheridAAI-1612-2021tr_TR
dc.contributor.researcheridEBN-1186-2022tr_TR
dc.contributor.scopusid50261655300tr_TR
dc.contributor.scopusid6508156530tr_TR
dc.contributor.scopusid25650627600tr_TR
dc.contributor.scopusid55665145000tr_TR
dc.contributor.scopusid6602965754tr_TR
dc.contributor.scopusid6603238737tr_TR
dc.contributor.scopusid6602604390tr_TR
dc.contributor.scopusid9637821500tr_TR
dc.date.accessioned2022-09-09T12:12:56Z
dc.date.available2022-09-09T12:12:56Z
dc.date.issued2015-02-10
dc.description.abstractTriple negative breast cancer (TNBC) is the most aggressive and poorly understood subclass of breast cancer (BC). Over the recent years, miRNA expression studies have been providing certain detailed overview that aberrant expression of miRNAs is associated with TNBC. Although TNBC tumors are strongly connected with loss of function of BRCA genes, there is no knowledge about the effect of BRCA mutation status on miRNA expressions in TNBC cases. The aims of this study were to evaluate the expression profile of miRNAs that plays role in TNBC progression and the role of BRCA mutations in their regulation. The expression level of BC associated 13 miRNAs was analyzed in 7 BRCA mutations positive, 6 BRCA mutations negative TNBC cases and 20 non-tumoral tissues using RT-PCR. According to RT2 Profiler PCR Array Data Analysis, let-7a expression was 4.67 fold reduced in TNBCs as compared to normal tissues (P = 0.031). In addition, miR-200c expression was 5.75 fold reduced in BRCA mutation positive TNBC tumors (P = 0.005). Analysis revealed a negative correlation between miR-200c and VEGFA expressions (r = -468). Thus, miR-200c may be involved in invasion and metastasis in TNBC cases with BRCA mutation. In this study we provide the knowledge on the first report of association between microRNA-200c and BRCA mutations in TNBC. Further studies and evaluations are required, but this miRNA may provide novel therapeutic molecular targets for TNBC treatment and new directions for the development of anticancer drugs.en_US
dc.identifier.citationErtürk, E. vd. (2015). "BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer". Gene, 556(2), 163-169.en_US
dc.identifier.endpage169tr_TR
dc.identifier.issn0378-1119
dc.identifier.issn1879-0038
dc.identifier.issue2tr_TR
dc.identifier.pubmed25445393tr_TR
dc.identifier.scopus2-s2.0-84919872180tr_TR
dc.identifier.startpage163tr_TR
dc.identifier.urihttps://doi.org/10.1016/j.gene.2014.11.047
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0378111914013249
dc.identifier.urihttp://hdl.handle.net/11452/28614
dc.identifier.volume556tr_TR
dc.identifier.wos000349589800012tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.bapUAP(T)-2011/1tr_TR
dc.relation.journalGeneen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBRCA1/2 gene mutationsen_US
dc.subjectMicroRNAen_US
dc.subjectMiR-200cen_US
dc.subjectTriple negative breast canceren_US
dc.subjectEpithelial-mesenchymal transitionen_US
dc.subjectDown-regulationen_US
dc.subjectOvarian-canceren_US
dc.subjectFeedback loopen_US
dc.subjectFamilyen_US
dc.subjectZeb1en_US
dc.subjectMicroRNA-200cen_US
dc.subjectProgressionen_US
dc.subjectMetastasisen_US
dc.subjectResistanceen_US
dc.subject.emtreeBRCA1 proteinen_US
dc.subject.emtreeBRCA1 protein, humanen_US
dc.subject.emtreeBRCA2 proteinen_US
dc.subject.emtreeBRCA2 protein, humanen_US
dc.subject.emtreeMicroRNAen_US
dc.subject.emtreeMırn200 microrna, humanen_US
dc.subject.emtreeMirnlet7 microRNA, humanen_US
dc.subject.emtreeVasculotropin Aen_US
dc.subject.emtreeVEGFA protein, humanen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeCancer growthen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeGene expression profilingen_US
dc.subject.emtreeGene expression regulationen_US
dc.subject.emtreeGene mutationen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHuman tissueen_US
dc.subject.emtreeLet 7a geneen_US
dc.subject.emtreeOncogeneen_US
dc.subject.emtreeReverse transcription polymerase chain reactionen_US
dc.subject.emtreeTriple negative breast canceren_US
dc.subject.emtreeTumor invasionen_US
dc.subject.emtreeVEGFA geneen_US
dc.subject.emtreeDisease courseen_US
dc.subject.emtreeGeneticsen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreeMutationen_US
dc.subject.emtreePathologyen_US
dc.subject.emtreeTriple negative breast canceren_US
dc.subject.meshAdulten_US
dc.subject.meshBRCA1 proteinen_US
dc.subject.meshBRCA2 proteinen_US
dc.subject.meshDisease progressionen_US
dc.subject.meshFemaleen_US
dc.subject.meshGene expression regulationen_US
dc.subject.meshNeoplasticen_US
dc.subject.meshHumansen_US
dc.subject.meshMicroRNAsen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshMutationen_US
dc.subject.meshTriple negative breast neoplasmsen_US
dc.subject.meshVascular endothelial growth factor Aen_US
dc.subject.scopusCirculating Microrna; Stomach Neoplasms; Breast Neoplasmsen_US
dc.subject.wosGenetics & Heredityen_US
dc.titleBRCA mutations cause reduction in miR-200c expression in triple negative breast canceren_US
dc.typeArticle
dc.wos.quartileQ3en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: